IFN-beta 1b treatment of relapsing multiple sclerosis has no effect on CD3-induced inflammatory or counterregulatory anti-inflammatory cytokine secretion ex vivo after nine months (Q73669697)
Jump to navigation
Jump to search
scientific article published on 01 June 1997
Language | Label | Description | Also known as |
---|---|---|---|
English | IFN-beta 1b treatment of relapsing multiple sclerosis has no effect on CD3-induced inflammatory or counterregulatory anti-inflammatory cytokine secretion ex vivo after nine months |
scientific article published on 01 June 1997 |
Statements
IFN-beta 1b treatment of relapsing multiple sclerosis has no effect on CD3-induced inflammatory or counterregulatory anti-inflammatory cytokine secretion ex vivo after nine months (English)
S A Brod
L D Nelson
M Khan